Value Drug News Today

On Friday, August 25, 2023, the U.S. Court of Appeals For The District Of Columbia Circuit affirmed dismissal of an antitrust action brought by the Federal Trade Commission...

/PRNewswire/ -- TraceLink Inc., the leading digital network platform company enabling end-to-end product orchestration by connecting more than 290,000...

/PRNewswire/ -- TraceLink Inc., the leading digital network platform company enabling end-to-end product orchestration by connecting more than 290,000...

Local history 50 years ago: 1973 In ceremonies at DelGrosso’s Restaurant in Tipton, George’s TV of Altoona, owned by George Thomas and opened in 1966, w

A federal judge last week rejected a bid by pharmacy chain Value Drug Co. to certify a class of roughly 50 purchasers of Takeda Pharmaceuticals' anti-gout drug Colcrys alleging that the company engaged in anticompetitive deals to stave off generic competition.

Dear Colleague, A couple of months ago in NCPA Executive Update, I encouraged readers to tell their story. That time I was talking about the FTC. NCPA serves as the megaphone for uniting the voices of our independent pharmacy owners. Many of you have taken action, and it's paying off on multiple issues.

June

There’s a lot going on right now that affects your business. With an election around the corner, an announced FTC investigation into PBMs, CMS rulemaking, and more, NCPA is targeting August as a month to turn up the heat on members of Congress. We’ll tell you all about it at a webinar, Turn Up the Heat - NCPA's Guide to Grassroots Action, sponsored by RxSafe, Pharmacists Mutual, and Value Drug Co.

Our world has changed dramatically, and we must do everything we can to ensure Pennsylvania communities have quick and ample access to vaccinations. During the pandemic, the federal government estimates that pharmacies provided more than two of every three covid-19 vaccine doses to Americans. A recent study by the Journal

A Pennsylvania federal judge threw out a lawsuit accusing drugmakers of participating in a conspiracy to delay a generic version of Takeda Pharmaceuticals' anti-gout drug Colcrys, telling pharmacy chain Value Drug Co. that its complaint lacked a plausible single horizontal conspiracy.